CC
AGN

Colrain Capital’s Allergan plc AGN Stock Holding History

Colrain Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,515
Closed -$1.69M – 37
2020
Q1 		$1.69M Sell
9,515
-2,150
-18% -$405K 3.17% 16
2019
Q4 		$2.23M Sell
11,665
-700
-6% -$126K 2.34% 16
2019
Q3 		$2.08M Hold
12,365
– – 2.29% 18
2019
Q2 		$2.07M Sell
12,365
-2,715
-18% -$376K 2.32% 18
2019
Q1 		$2.21M Sell
15,080
-4,485
-23% -$650K 2.59% 20
2018
Q4 		$2.62M Sell
19,565
-1,325
-6% -$217K 3.4% 15
2018
Q3 		$3.98M Buy
20,890
+250
+1% +$45.9K 4.25% 12
2018
Q2 		$3.44M Sell
20,640
-3,650
-15% -$586K 4.06% 11
2018
Q1 		$4.09M Buy
24,290
+22,190
+1,057% +$3.72M 4.33% 8
2017
Q4 		$344K Sell
2,100
-31,915
-94% -$5.73M 0.28% 39
2017
Q3 		$6.97M Buy
34,015
+4,575
+16% +$1.06M 3.2% 10
2017
Q2 		$7.16M Buy
29,440
+11,825
+67% +$2.78M 2.9% 11
2017
Q1 		$4.21M Sell
17,615
-5,325
-23% -$1.24M 1.27% 30
2016
Q4 		$4.82M Buy
22,940
+2,795
+14% +$579K 1.01% 33
2016
Q3 		$4.64M Sell
20,145
-5,325
-21% -$1.3M 1.05% 32
2016
Q2 		$5.89M Buy
25,470
+14,120
+124% +$3.26M 1.17% 31
2016
Q1 		$3.04M Buy
+11,350
New +$3.25M 0.53% 42

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Colrain Capital's AGN Position: Q2 2020 in Review

Colrain Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,515 shares — an estimated $1.69M sold.

Colrain Capital first reported a position in AGN in Q1 2016 and held it in 17 quarters. The position peaked at $7.16M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Colrain Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Colrain Capital sold 9,515 Allergan plc shares in Q2 2020, an estimated $1.69M.
  • Colrain Capital first reported a position in Allergan plc in Q1 2016 and held it in 17 quarters.
  • Colrain Capital's Allergan plc position peaked at $7.16M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Colrain Capital's 13F filing for Q2 2020, filed 10 Aug 2020.